Viewing Study NCT05438251

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2025-12-25 @ 9:36 PM
Study NCT ID: NCT05438251
Status: TERMINATED
Last Update Posted: 2024-05-16
First Post: 2022-06-24
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: Exploring the Effect of Fespixon Cream for the Treatment of Diabetic Foot Ulcers (TEXAS 3A, 3B)
Sponsor: Oneness Biotech Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetic Foot Ulcer (DFU) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ON101 View
None Fespixon View
None Diabetic Foot Ulcer View
None TEXAS 3A/3B View